1933 Industries (CSE: TGIF) not impacted by FDA warning letter to CuraLeaf (CSE: CURA)
Just a quick comment to let you know that 1933 Industries (CSE: TGIF) does not believe it is impacted by last week’s report regarding CuraLeaf’s (CSE: CURA) “warning letter” from the U.S. Food and Drug Administration (FDA) relating to “unsubstantiated claims” regarding some of CURA’s CBD infused products.
I understand that TGIF has been very careful to avoid any unsubstantiated product claims about its Canna Hemp, CBD products. These are now available in nearly 1,000 stores in 46 states including over 350 legal dispensaries. I put TGIF’s market cap at approximately one times sales for the year to end July 2020 which makes it a very attractive long term growth candidate for portfolios.